Probiotics: A new frontier for infection control

Journal of Hospital Infection

Volumn 84, Issue 1, 2013, Pages 1-4

  Seale, J V ^a   Millar, M ^a  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

Infection control; Necrotising enterocolitis; Probiotics

Indexed keywords

PROBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; CLINICAL PRACTICE; DRUG SENSITIVITY; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION RISK; PRACTICE GUIDELINE; REVIEW;

CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; HUMANS; INFECTION CONTROL; PROBIOTICS; RISK FACTORS;

EID: 84876324083     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2013.01.005     Document Type: Review

References (32)

1. Metchnikoff E. The prolongation of life: optimistic studies 1908, G.P. Putnam's Sons, New York & London.
2. Guidelines for the evaluation of probiotics in food 2002, Joint Food and Agriculture Organization/World Health Organization Working Group, Joint FAO/WHO, London, Ontario, Canada.
3. Miele E., Pascarella F., Giannetti E., Quaglietta L., Baldassano R.N., Staiano A. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol 2009, 104:437-443.
4. Niedzielin K., Kordecki H., Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2001, 13:1143-1147.
5. Gareau M.G., Wine E., Rodrigues D.M., et al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 2011, 60:307-317.
6. Bravo J.A., Forsythe P., Chew M.V., et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 2011, 108:16050-16055.
7. Deshpande G., Rao S., Patole S., Bulsara M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010, 125:921-930.
8. Tarnow-Mordi W.O., Wilkinson D., Trivedi A., Brok J. Probiotics reduce all-cause mortality and necrotizing enterocolitis: it is time to change practice. Pediatrics 2010, 125:1068-1070.
9. Patel R.M., Lin P.W. Developmental biology of gut-probiotic interaction. Gut Microbes 2010, 1:186-195.
10. Morrow L.E., Gogineni V., Malesker M.A. Synbiotics and probiotics in the critically ill after the PROPATRIA trial. Curr Opin Clin Nutr Metab Care 2012, 15:147-150.
11. Sanders M.E., Akkermans L.M., Haller D., et al. Safety assessment of probiotics for human use. Gut Microbes 2010, 1:164-185.
12. Vankerckhoven V., Huys G., Vancanneyt M., et al. Biosafety assessment of probiotics used for human consumption: recommendations from the EU-PROSAFE project. Trends Food Sci Technol 2008, 19:102-114.
13. Venugopalan V., Shriner K.A., Wong-Beringer A. Regulatory oversight and safety of probiotic use. Emerg Infect Dis 2010, 16:1661-1665.
14. Reid G. Microbiology: categorize probiotics to speed research. Nature 2012, 485:446.
15. Houck P.W., Nelson J.D., Kay J.L. Fatal septicemia due to Staphylococcus aureus 502A. Report of a case and review of the infectious complications of bacterial interference programs. Am J Dis Child 1972, 123:45-48.
16. Saxelin M., Chuang N.H., Chassy B., et al. Lactobacilli and bacteremia in southern Finland, 1989-1992. Clin Infect Dis 1996, 22:564-566.
17. Ohishi A., Takahashi S., Ito Y., et al. Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele. J Pediatr 2010, 156:679-681.
18. Kunz A.N., Noel J.M., Fairchok M.P. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr 2004, 38:457-458.
19. Land M.H., Rouster-Stevens K., Woods C.R., Cannon M.L., Cnota J., Shetty A.K. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005, 115:178-181.
20. Broughton R.A., Gruber W.C., Haffar A.A., Baker C.J. Neonatal meningitis due to Lactobacillus. Pediatr Infect Dis 1983, 2:382-384.
21. Kitajima H., Sumida Y., Tanaka R., Yuki N., Takayama H., Fujimura M. Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 1997, 76:F101-F107.
22. Millar M.R., Bacon C., Smith S.L., Walker V., Hall M.A. Enteral feeding of premature infants with Lactobacillus GG. Arch Dis Child 1993, 69:483-487.
23. Millar M., Wilks M., Fleming P., Costeloe K. Should the use of probiotics in the preterm be routine?. Arch Dis Child Fetal Neonatal Ed 2012, 97:F70-F74.
24. Zhou J.S., Pillidge C.J., Gopal P.K., Gill H.S. Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains. Int J Food Microbiol 2005, 98:211-217.
25. Fons M., Hégé T., Ladiré M., Raibaud P., Ducluzeau R., Maguin E. Isolation and characterization of a plasmid from Lactobacillus fermentum conferring erythromycin resistance. Plasmid 1997, 37:199-203.
26. Ahn C., Collins-Thompson D., Duncan C., Stiles M.E. Mobilization and location of the genetic determinant of chloramphenicol resistance from Lactobacillus plantarum caTC2R. Plasmid 1992, 27:169-176.
27. Borriello S.P., Hammes W.P., Holzapfel W., et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003, 36:775-780.
28. Boesten R.J., de Vos W.M. Interactomics in the human intestine: Lactobacilli and Bifidobacteria make a difference. J Clin Gastroenterol 2008, 42:S163-S167.
29. Kleerebezem M., Vaughan E.E. Probiotic and gut lactobacilli and bifidobacteria: molecular approaches to study diversity and activity. Annu Rev Microbiol 2009, 63:269-290.
30. Gerritsen J., Smidt H., Rijkers G.T., de Vos W.M. Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr 2011, 6:209-240.
31. Ammor M.S., Flórez A.B., Mayo B. Antibiotic resistance in non-enterococcal lactic acid bacteria and bifidobacteria. Food Microbiol 2007, 24:559-570.
32. Department of Health NHS guide to bottle feeding 2012, Williams Lea, London.